Correction: Proanthocyanidins protect against cadmium-induced diabetic nephropathy through p38 MAPK and Keap1/Nrf2 signaling pathways
Frontiers in Pharmacology · 29.04.2026 · 17
DOI: 10.3389/fphar.2026.1842414 ↗Kurz gefasst
Korrektur in der Zeitschrift Frontiers in Pharmacology, online erschienen am 29.04.2026. Verfasst von Pin Gong und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Food and Biotechnology, Shaanxi University of Science and Technology, Xi'an, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Food and Biotechnology, Shaanxi University of Science and Technology, Xi'an, China.
- School of Chemistry and Chemical Engineering, Xi'an University of Science and Technology, Xi'an, China.
Zitieren
APA
Gong, P., Wang, P., Pi, S., Guo, Y., Pei, S., Yang, W., Chang, X., Wang, L., & Chen, F. (2026). Correction: Proanthocyanidins protect against cadmium-induced diabetic nephropathy through p38 MAPK and Keap1/Nrf2 signaling pathways. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1842414
Vancouver
Gong P, Wang P, Pi S, Guo Y, Pei S, Yang W, et al. Correction: Proanthocyanidins protect against cadmium-induced diabetic nephropathy through p38 MAPK and Keap1/Nrf2 signaling pathways. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1842414
BibTeX
@article{Gong2026,
author = {Gong, Pin and Wang, Peipei and Pi, Sihui and Guo, Yuxi and Pei, Shuya and Yang, Wenjuan and Chang, Xiangna and Wang, Lan and Chen, Fuxin},
title = {Correction: Proanthocyanidins protect against cadmium-induced diabetic nephropathy through p38 MAPK and Keap1/Nrf2 signaling pathways},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1842414}
}
EUVIMED